[Home ] [Archive]   [ فارسی ]  
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Indexing and Abstracting
Index Medicus for the Eastern Mediterranean Region (IMEMR)
Index Copernicus
ResearchBible
J-Gate
I۲OR
ROAD
CiteFactor
Scientific Indexing Services
SID
Magiran
Google Scholar
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISMU
..
:: Volume 7, Issue 3 (Autumn 2025) ::
J Mar Med 2025, 7(3): 210-228 Back to browse issues page
A Review of Six Decades of Lateral Flow Immunoassay (LFIA) Development: From Clinical Applications and Metabolic Marker Detection to Its Pivotal Role in COVID-19 Diagnosis and the Development of Rapid Kits in Aquaculture
Mohammad Jalil Zorriehzahra , Mina Ziarati , Monireh Faeed , Parisa Mohammadisefat , Laleh Yazdanpanah Goharrizi * , Sana Yousefian Jezi
Department of Fishery Science, Microbiology, Agricultural and Natural Recourses Research and Education Center of Kerman. Agricultural Research Education and Extension Organization (AREEO), Tehran, Iran , l.yazdanpanah@areeo.ac.ir
Abstract:   (30 Views)
Lateral Flow Immunoassay (LFIA) technologies, also known as immunochromatographic assays, have been extensively utilized over the past six decades for disease diagnosis. These systems enable the rapid detection of biological ligands in clinical and environmental samples. Their primary advantages include low cost, accessibility, rapid turnaround time, and ease of use without the need for sophisticated laboratory equipment. The appeal of these portable diagnostic tools stems mainly from their acceptable analytical sensitivity and specificity, coupled with the visual interpretability of results. Due to these features, LFIA has gained significant traction, particularly in developing countries and emergency medical settings. In Iran, alongside global advancements, opportunities for the refinement and expansion of this technology have emerged.
This article provides a structured review of the evolutionary trajectory, advantages, limitations, and modern applications of LFIA across various fields, including COVID-19 diagnosis. Furthermore, it highlights recent achievements in fisheries and aquaculture, such as the design and development of rapid diagnostic kits for major viral pathogens, including Viral Nervous Necrosis (VNN), Viral Hemorrhagic Septicemia (VHS), and Koi Herpesvirus (KHV).
Keywords: Lateral Flow Immunoassay (LFIA), Rapid COVID-19 Diagnosis, Aquatic Pathogens, Viral Disease Detection, Rapid Diagnostic Kits
Full-Text [PDF 992 kb]   (33 Downloads)    
Type of Study: Review | Subject: Marine Medicine
Received: 2025/11/15 | Accepted: 2025/11/30 | Published: 2025/12/1
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zorriehzahra M J, Ziarati M, Faeed M, Mohammadisefat P, Yazdanpanah Goharrizi L, Yousefian Jezi S. A Review of Six Decades of Lateral Flow Immunoassay (LFIA) Development: From Clinical Applications and Metabolic Marker Detection to Its Pivotal Role in COVID-19 Diagnosis and the Development of Rapid Kits in Aquaculture. J Mar Med 2025; 7 (3) :210-228
URL: http://jmarmed.ir/article-1-522-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 3 (Autumn 2025) Back to browse issues page
مجله طب دریا Journal of Marine Medicine
Persian site map - English site map - Created in 0.03 seconds with 39 queries by YEKTAWEB 4732